Skip to main content

Biomedical informatics' Rong Xu discusses Ozempic's potential to lower risk of Alzheimer's disease

MEDIA | October 29, 2024
STORY BY: EDITORIAL STAFF

Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
New York PostRong Xu, professor of biomedical informatics, discussed how Type 2 diabetics may have a shot at significantly lowering their risk of Alzheimer’s disease if they take Ozempic instead of other diabetes medications. “Preclinical research has suggested that semaglutide may protect against neurodegeneration and neuroinflammation,” said Xu.